Sign in

jitchatterjee1.bsky.social

@jitchatterjee1.bsky.social
26 followers 32 following 3 posts
PostsRepliesMedia
jitchatterjee1.bsky.social @jitchatterjee1.bsky.social · 05/04/2026
Grateful for the support and the team effort —excited to continue building on these findings.
000
Reposted by @jitchatterjee1.bsky.social
David H. Gutmann, MD PhD @dhgutmann.bsky.social · 05/04/2026
Congratulations to @jitchatterjee1.bsky.social and team on this preclinical analysis.
001
jitchatterjee1.bsky.social @jitchatterjee1.bsky.social · 23/02/2026
Nothing lifts lab morale like a star undergrad carrying forward the sacred banana bread tradition. Proof that great science (and great mentors) rise together @gutmannlab.bsky.social
010
Reposted by @jitchatterjee1.bsky.social
David H. Gutmann, MD PhD @dhgutmann.bsky.social · 10/12/2025
So proud to partner with Penny's Flight Foundation.
021
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 03/12/2025
Celebrations are in full swing in the Gutmann Lab! 🎉 Yesterday’s Labsgiving and white elephant were a great way to appreciate the wonderful people who make this science family special. Wishing everyone a happy holiday season! 🎁❄️
053
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 06/10/2025
Excited to share our latest work in Neuro-Oncology Advances! 🥳 After comparing several potential therapies, we identified lamotrigine as a promising therapy for NF1 optic glioma, showing both tumor reduction and vision protection. Check out the work of our great team!
academic.oup.com
Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation
AbstractBackground. Authenticated preclinical brain tumor models provide unprecedented opportunities to evaluate next-generation treatments. However, some
0135
Reposted by @jitchatterjee1.bsky.social
Corina Anastasaki @corinaanast.bsky.social · 02/09/2025
Shameless self promotion of our new paper. So very excited to share our new work uncovering coupling of glutamate receptors ⚡️and RTKs to enable growth of low-grade gliomas 🧠 @gutmannlab.bsky.social @washuneurology.bsky.social
0127
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 04/08/2025
We are so proud of Rasha and Rui's new paper! Their single cell reveals hidden diversity in CD8+ exhausted T cells across cancers, shedding light on why patients respond differently to immunotherapy and bringing us closer to more effective therapies. Don’t miss this exciting advance from our team!
tandfonline.com
Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8+ exhausted T cell populations with different immune checkpoint inhibitor responses
In most cancers, T lymphocytes comprise an essential cellular component of the non-neoplastic microenvironment, where they have the capacity to both suppress and support tumor growth. One specializ...
294
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 22/07/2025
This past weekend we celebrated the 3rd Annual NF Family Day - a special time to honor our patients and families, build community, and have fun! From shaved ice and giant slides to visits from the St. Louis Fire and Police Department, we’re grateful for the support and another year moving forward.
052
Reposted by @jitchatterjee1.bsky.social
David H. Gutmann, MD PhD @dhgutmann.bsky.social · 21/06/2025
I could not be more fortunate and proud to work with such a great group of people.
011
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 25/01/2025
Congratulations to @jitchatterjee1.bsky.social on the acceptance of his cool new paper‼️🦠🦠🦠🦠
071
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 17/01/2025
13 glorious years of working with @corinaanast.bsky.social at @gutmannlab.bsky.social. 🎂
174
Reposted by @jitchatterjee1.bsky.social
Corina Anastasaki @corinaanast.bsky.social · 30/11/2024
Happy holiday season from all of us in the @gutmannlab.bsky.social 🎉 🦃🎉 @jitchatterjee1.bsky.social @rashab.bsky.social @lsw18.bsky.social
073
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 28/11/2024
Excited to share a new paper from @rashab.bsky.social on exhausted CD8 T cells and low grade brain tumors in #NF1. nam10.safelinks.protection.outlook.com?url=https%3A...
nam10.safelinks.protection.outlook.com
Human single cell RNA-sequencing reveals a targetable CD8+ exhausted T cell population that maintains mouse low-grade glioma growth
Nature Communications - With the emergence of immune checkpoint inhibitor therapies for cancer, the authors use single-cell sequencing to assess exhausted T cell content in human glioma samples and...
0247
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 26/11/2024
Best research group ever! Happy Holidays to all from @gutmannlab.bsky.social
0144
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 25/11/2024
Banner day in @gutmannlab.bsky.social. Thank you to Dr. Lee for allowing us to continue to grow and flourish!
2141
Reposted by @jitchatterjee1.bsky.social
Gutmann Lab @gutmannlab.bsky.social · 23/11/2024
Great presentations again on day 2 of @neuroonc.bsky.social. #cancerneuroscience every day. Stay tuned for @corinaanast.bsky.social tomorrow.
0113
jitchatterjee1.bsky.social @jitchatterjee1.bsky.social · 24/11/2024
@corinaanast.bsky.social Ending the great cancer neuroscience season in style #SNO2024
020